One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes

Diabetes Care

Volumn 31, Issue 8, 2008, Pages 1650-1655

  Abdul Ghani, Muhammad A ^a   Ali, Nibal ^a   Abdul Ghani, Tamam ^a   Defronzo, Ralph A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; BLOOD; BODY MASS; BODY SIZE; DIET RESTRICTION; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; RISK FACTOR; UNITED STATES;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; BODY SIZE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; TEXAS;

EID: 49649118040     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0225     Document Type: Article

References (22)

1. Diabetes Prevention Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
2. Unwin N, Shaw J, Zimmet P, Alberti KGMM: Impaired glucose tolerance and impaired fasting glycemia: the current status on definition and intervention. Diabet Med 19:708-723, 2002
3. Abdul-Ghani MA, Williams K, DeFronzo R, Stern M: Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care 29:1613-1618, 2006
4. Stern MP, Williams K, Haffner SM: Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136: 575-581, 2002
5. Wannamethee SG, Shaper AG, Lennon L, Morris RW: Metabolic syndrome vs Fra- mingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165:2644-2650, 2005
6. Kanaya AM, Wassel Fyr CL, de Rekeneire N, Shorr RI, Schwartz AV, Goodpaster BH, Newman AB, Harris T, Barrett-Connor E: Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. Diabetes Care 28:404-408, 2005
7. McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY: Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. Diabetes Care 26:758-763, 2003
8. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM, the San Antonio Heart Study: The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 26:3153-3159, 2003
9. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M: What is the best predictor of future type 2 diabetes? Diabetes Care 30: 1544-1548, 2007
10. Stern SE, Williams K, Ferrannini E, De- Fronzo RA, Bogardus C, Stern MP: Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 54:333-339, 2005
11. Stern MP, Rosenthal M, Haffner SM, Ha- zuda HP, Franco LJ: Sex difference in the effects of sociocultural status on diabetes and cardiovascularrisk factors inMexican Americans: the San Antonio Heart Study. Am J Epidemiol 120:834-851, 1984
12. Stern MP, Patterson JK, Haffner SM, Ha- zuda HP, Mitchell BD: Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey. JAMA 262:360 -364, 1989
13. Burke JP, Williams K, Gaskill SP, Hazuda HP, Haffner SM, Stern MP: Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med 159: 1450-1456, 1999
14. WHO Study Group: Diabetes Mellitus. Geneva, World Health Org., 1985 (Tech. rep. ser., no. 727)
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001
16. Clark LA, Pregibon D: Tree model analysis. In Statistical Models. Chambers JM, Hastie TJ, Eds. Pacific Grove, CA, Wads- worth and Brooks, 1992
17. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
18. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B, the American Diabetes Association: Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30:753-759, 2007
19. DeFronzo RA: Lilly lecture 1987: The triumvirate: (3-cell, muscle, liver. A collu-sion responsible for NIDDM. Diabetes 37: 667-687, 1988
20. Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA: Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 55:1430-1435, 2006
21. Abdul-Ghani MA, Tripathy D, DeFronzo RA: Contributions of (3-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and im-paired fasting glucose. Diabetes Care 29:1130 -1139, 2006
22. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA: Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30: 89-94, 2007